 | • レポートコード：MRC2302F0103 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、241ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に246.9億ドルであった世界のプロテオミクス市場規模が、2022年に281.9億ドルになり、2027年まで年平均14.35%で成長して552.2億ドルまで拡大すると予測しています。本レポートは、プロテオミクスの世界市場について調査し、市場の動向を明らかにした資料であり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別（クロマトグラフィー、電気泳動、タンパク質マイクロアレイ、分光器）分析、提供別（バイオインフォマティクスソフトウェア・サービス、コアプロテオミクスサービス）分析、試薬別（クロマトグラフィー試薬、電気泳動試薬、免疫測定試薬、タンパク質分画試薬、その他）分析、用途別（臨床診断、創薬）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など以下の構成でまとめています。また、Agilent Technologies, Inc.、Bruker Corporation、Creative Proteomics、Danaher Corporation、Luminex Corporation、Merck KGaA、Perkinelmer, Inc.、Promega Corporation、Thermo Fisher Scientific, Inc.、Waters Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のプロテオミクス市場規模：技術別 - クロマトグラフィーの市場規模 - 電気泳動の市場規模 - タンパク質マイクロアレイの市場規模 - 分光器の市場規模 ・世界のプロテオミクス市場規模：提供別 - バイオインフォマティクスソフトウェア・サービスにおける市場規模 - コアプロテオミクスサービスにおける市場規模 ・世界のプロテオミクス市場規模：試薬別 - クロマトグラフィー試薬の市場規模 - 電気泳動試薬の市場規模 - 免疫測定試薬の市場規模 - タンパク質分画試薬の市場規模 - その他の市場規模 ・世界のプロテオミクス市場規模：用途別 - 臨床診断における市場規模 - 創薬における市場規模 ・世界のプロテオミクス市場規模：地域別 - 南北アメリカのプロテオミクス市場規模 アメリカのプロテオミクス市場規模 カナダのプロテオミクス市場規模 ブラジルのプロテオミクス市場規模 … - アジア太平洋のプロテオミクス市場規模 日本のプロテオミクス市場規模 中国のプロテオミクス市場規模 インドのプロテオミクス市場規模 韓国のプロテオミクス市場規模 台湾のプロテオミクス市場規模 … - ヨーロッパ/中東/アフリカのプロテオミクス市場規模 イギリスのプロテオミクス市場規模 ドイツのプロテオミクス市場規模 フランスのプロテオミクス市場規模 ロシアのプロテオミクス市場規模 … - その他地域のプロテオミクス市場規模 ・競争状況 ・企業情報 |
The Global Proteomics Market size was estimated at USD 24.69 billion in 2021 and expected to reach USD 28.19 billion in 2022, and is projected to grow at a CAGR 14.35% to reach USD 55.22 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Proteomics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Technology, the market was studied across Chromatography, Electrophoresis, Protein Microarrays, Spectroscopy, and X-Ray Crystallography. The Chromatography is further studied across Affinity Chromatography, HPLC, Ion Chromatography, and Supercritical Fluid Chromatography. The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis. The Protein Microarrays is further studied across Biochips and Microarray Instruments. The Spectroscopy is further studied across CD Spectroscopy, Mass Spectroscopy, and NMR Spectroscopy.
Based on Offerings, the market was studied across Bioinformatics Software and Services and Core Proteomics Services. The Bioinformatics Software and Services is further studied across Bioinformatics Databases, Bioinformatics Services, and Bioinformatics Tools. The Core Proteomics Services is further studied across Custom Assay Services, Protein Characterization Services, Protein Identification Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, and Quantitative Proteomics Services.
Based on Reagent, the market was studied across Chromatography Reagents, Electrophoresis Reagents, Immunoassay Reagents, Protein Fractionation Reagents, Protein Microarray Reagents, Spectroscopy Reagents, and X-Ray Crystallography Reagents.
Based on Application, the market was studied across Clinical Diagnostics and Drug Discovery.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Proteomics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Proteomics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Proteomics Market, including Agilent Technologies, Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, Luminex Corporation, Merck KGaA, Perkinelmer, Inc., Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Proteomics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Proteomics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Proteomics Market?
4. What is the competitive strategic window for opportunities in the Global Proteomics Market?
5. What are the technology trends and regulatory frameworks in the Global Proteomics Market?
6. What is the market share of the leading vendors in the Global Proteomics Market?
7. What modes and strategic moves are considered suitable for entering the Global Proteomics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for personalized medicine
5.1.1.2. Technology advancements
5.1.1.3. Personalized proteomics for precision health
5.1.1.4. Increasing R&D and government funding in pharmaceuticals and biotechnology
5.1.2. Restraints
5.1.2.1. High cost associated with the instruments
5.1.3. Opportunities
5.1.3.1. Growing prominence of nanoproteomics
5.1.3.2. Integration of Omics data in biomedical sciences
5.1.3.3. High growth potential in emerging countries
5.1.4. Challenges
5.1.4.1. Data management in proteomics research
5.1.4.2. Low ratio biomarkers discovery-to-approval ratio
5.2. Cumulative Impact of COVID-19
6. Proteomics Market, by Technology
6.1. Introduction
6.2. Chromatography
6.3.1. Affinity Chromatography
6.3.2. HPLC
6.3.3. Ion Chromatography
6.3.4. Supercritical Fluid Chromatography
6.3. Electrophoresis
6.4.1. Capillary Electrophoresis
6.4.2. Gel Electrophoresis
6.4. Protein Microarrays
6.5.1. Biochips
6.5.2. Microarray Instruments
6.5. Spectroscopy
6.6.1. CD Spectroscopy
6.6.2. Mass Spectroscopy
6.6.3. NMR Spectroscopy
6.6. X-Ray Crystallography
7. Proteomics Market, by Offerings
7.1. Introduction
7.2. Bioinformatics Software and Services
7.3.1. Bioinformatics Databases
7.3.2. Bioinformatics Services
7.3.3. Bioinformatics Tools
7.3. Core Proteomics Services
7.4.1. Custom Assay Services
7.4.2. Protein Characterization Services
7.4.3. Protein Identification Services
7.4.4. Protein Purification Services
7.4.5. Protein Separation Services
7.4.6. Protein Sequencing Services
7.4.7. Quantitative Proteomics Services
8. Proteomics Market, by Reagent
8.1. Introduction
8.2. Chromatography Reagents
8.3. Electrophoresis Reagents
8.4. Immunoassay Reagents
8.5. Protein Fractionation Reagents
8.6. Protein Microarray Reagents
8.7. Spectroscopy Reagents
8.8. X-Ray Crystallography Reagents
9. Proteomics Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Drug Discovery
10. Americas Proteomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Proteomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Proteomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Bruker Corporation
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Creative Proteomics
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Danaher Corporation
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Luminex Corporation
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Merck KGaA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Perkinelmer, Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Promega Corporation
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Thermo Fisher Scientific, Inc.
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Waters Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing